Market News

NASDAQ:DXCM News

8 stories
zacks

DexCom Stock Up on Q2 Earnings & Revenue Beat, Margins Rise

DexCom, Inc. DXCM reported second-quarter 2026 adjusted earnings per share (EPS) of 70 cents, which beat the Zacks Consensus Estimate of 61 cents by 14.8%. The company reported adjusted EPS of 48 cents per share in the prior-year quarter.Revenues increased 13.1% year over year to $1.31 billion and…

Zacks en_IN
StocksUS
tradingview

DexCom, Inc. Stock 12‑Month Price Target Raised to $93.38, Implies 25% Upside

Explore more price target data and ratings for DexCom, Inc. on the Forecasts tab, and track all previous and future analyst recommendations for DexCom, Inc. in the dedicated News Flow.Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc. This information is not a…

TradingView en_IN
StocksUS
stockstory

DexCom Earnings: What To Look For From DXCM

Medical device company DexCom NASDAQ:DXCMwill be reporting results this Thursday after the bell. Here’s what to look for.DexCom beat analysts’ revenue expectations last quarter, reporting revenues of $1.19 billion, up 15% year on year. It was a satisfactory quarter for the company, with a beat of a…

Stock Story en_IN
StocksUS